Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Brazil — Brazilian Health Regulatory Agency

Tracked across 4 events · 26 articles · First seen Jun 08, 2026 · Last active Sep 08, 2026

Sentiment
2
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Regulatory
Impact: Anvisa is the regulatory body reviewing the application; its approval decision will determine vaccine availability in Brazil.
Jul 13, 2026 · 6 articles
2 20
International
Impact: The India — Central Drugs Standard Control Organisation-Brazil — Brazilian Health Regulatory Agency MoU facilitates regulatory cooperation, potentially easing market entry for Indian pharmaceuticals.
Aug 31, 2026 · 7 articles
4 -10
Regulatory
Impact: Brazil — Brazilian Health Regulatory Agency, Brazil's regulatory agency, approved the vaccine in late 2025, and the suspension raises questions about its initial approval process.
Jun 08, 2026 · 7 articles
1 0
Business
Regenerative Medical Technology Group, Inc. (RMTG), through its Cellgenic division, announced on September 8, 2026, that it has commenced local commercial arrangements in Colombia, including establishing local representation and developing relationships with physicians and medical…
Impact: Brazilian regulator; mentioned as comparable.
Sep 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Brazil — Brazilian Health Regulatory Agency live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.